Kate J. Wilkinson

Liverpool, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials.

Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials.

Journal: Cancers

Published: February 06, 2026

Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort Study.

Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort Study.

Journal: JCO oncology practice

Published: November 03, 2025

Documentation of Advance Care Planning in Early Phase Cancer Clinical Trials: An Australian Single-Centre Experience.

Documentation of Advance Care Planning in Early Phase Cancer Clinical Trials: An Australian Single-Centre Experience.

Journal: Cancers

Published: October 12, 2025

Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLER.

Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLER.

Journal: JNCI cancer spectrum

Published: June 17, 2025

Inclusion of Older Adults in Early-Phase Cancer Clinical Trials: Safety, Efficacy and a Way Forward.

Inclusion of Older Adults in Early-Phase Cancer Clinical Trials: Safety, Efficacy and a Way Forward.

Journal: Drugs & aging

Published: May 30, 2025

Evaluating patient diversity in early phase clinical trials in Australia through a prospective multicenter nonrandomized cohort study.

Evaluating patient diversity in early phase clinical trials in Australia through a prospective multicenter nonrandomized cohort study.

Journal: JNCI cancer spectrum

Published: December 23, 2024

The Prognostic and Predictive Utility of CDX2 in Colorectal Cancer.

The Prognostic and Predictive Utility of CDX2 in Colorectal Cancer.

Journal: International journal of molecular sciences

Published: July 18, 2024

Social Characteristics of Culturally and Linguistically Diverse Cancer Patients Enrolled in Early Phase Clinical Trials in South Western Sydney.

Social Characteristics of Culturally and Linguistically Diverse Cancer Patients Enrolled in Early Phase Clinical Trials in South Western Sydney.

Journal: Oncology

Published: April 25, 2024

Microsatellite Instability Testing and Prognostic Implications in Colorectal Cancer.

Microsatellite Instability Testing and Prognostic Implications in Colorectal Cancer.

Journal: Cancers

Published: April 14, 2024

Comparison of Prognostic Scores in Early Phase Clinical Trials: A 10-year Single Centre Australian Experience.

Comparison of Prognostic Scores in Early Phase Clinical Trials: A 10-year Single Centre Australian Experience.

Journal: Anticancer research

Published: February 10, 2024

Survival outcomes in older adults undergoing early phase clinical trials.

Survival outcomes in older adults undergoing early phase clinical trials.

Journal: Journal of geriatric oncology

Published: January 09, 2024

KRAS and BRAF Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort.

KRAS and BRAF Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort.

Journal: International journal of molecular sciences

Published: November 18, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026